Delivery Order SPE2DB22D3301-SPE2DB24FZ2HS

Award Date 8/7/24
Potential Completion Date 8/28/24
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $8,139.33 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation for the supply of 4,565,810 units of the pharmaceutical product Tafinlar 75 mg capsules. The order has an ultimate completion date of October 4, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical through December 2025 for delivering a range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,896.42, is for the delivery of Tafinlar 75mg capsules. The contract has a period of performance through March 12, 2025 and is a firm fixed-price contract. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the cancer medication Tafinlar (50 mg capsules). The contract has a firm fixed price of $30,424.90 and a performance period ending on May 22, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,792.82, is for the delivery of Tafinlar 75 mg capsules. It is a firm fixed-price delivery order contract with a period of performance through May 5, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading pharmaceutical sourcing and distribution company, to provide 120 capsules of the brand name cancer drug Tafinlar. The delivery order has a ceiling value of $16,278.68 and a period of performance through April 23, 2024. AmerisourceBergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,792.82 firm fixed-price contract is for the supply of 4,568,120,296 units of the prescription medication Tafinlar 75 mg capsule. The contract has a period of performance through May 23, 2025. This award is not associated with a set-aside program and is part of a larger $999,999,999.00 Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication TAFINLAR 75 MG CAPSULE 120S. The contract has a ceiling value of $8,896.41 and is a firm fixed-price delivery order with a completion date of June 9, 2025. The contract is not set-aside and was awarded on May 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of Tafinlar 50 mg capsules, a prescription medication, with a ceiling value of $6,313.86 and an ultimate completion date of October 28, 2024. The contract is a firm-fixed-price delivery order, and there is no set-aside designation. As one of the largest pharmaceutical distributors in the United States,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TAFINLAR 75 MG CAPSULE 120S, a pharmaceutical product, with a ceiling value of $17,792.82 and a performance period through June 30, 2025. The contract is a firm fixed price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAFINLAR 50 MG CAPSULE 120S, a pharmaceutical product. The contract is a delivery order with a firm fixed price of $13,836.26 and a completion date of June 30, 2025. The contract is not set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ2HS
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $16,278.68, is for the supply of Tafinlar 75 mg capsules. It is a firm fixed-price delivery order contract with an ultimate completion date of August 28, 2024.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This delivery order appears to be one of the task orders issued under that broader IDC vehicle. No set-aside designation is mentioned.

Generated 11/6/24, 9:03 AM